DC [10] [11] [12] [13] are seen in lesional but not perilesional skin of DD. The defective gene in DD is ATP2A2, 14 which encodes the sarco/endoplasmic reticulum Ca 2+ -ATPase (SERCA) isoform 2. SERCA2 is the only isoform of SERCA family members that is expressed in keratinocytes. 15 SERCA is a calcium pump that actively transports Ca 2+ from the cytosol to the lumen of the endoplasmic reticulum (ER) against a concentration gradient. 16 The primary consequence of SERCA dysfunction is reduced Ca 2+ content in the ER and increased Ca 2+ level in the cytosol. 17, 18 However, the specific role of SERCA2 in desmosomal adhesion is not well understood.
Impaired translocation of DP to the cell borders has been observed in cultured DD keratinocytes,
19
SERCA2 siRNAtransfected normal keratinocytes, 20 and SERCA inhibitor thapsigargin (TG)-treated cells. 17, 19, 21 Hobbs et al. show that siRNA knockdown of SERCA2 results in attenuated protein kinase C alpha signaling, which increases DP retention along keratin filaments and thus delays DP translocation to the cell borders.
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SERCA2 inhibition has also been shown to upregulate sphingosine production, which in turn affects the cell border localization of DP and E-cadherin via a yet unknown mechanism.
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Impaired trafficking of DC to the cell border has also been detected in keratinocytes treated with TG; however, in DD keratinocytes that were derived from unaffected skin of patients, DC trafficking was only slightly affected. 19 A recent study by Savignac et al. have detected some degree of ER stress response in DD keratinocyte culture. 22 A small portion of DC and E-cadherin was observed in the perinuclear region, which was partially colocalized with ER calnexin, indicative of ER retention. 22 However, whether SERCA2 deficiency can cause ER retention of DC remains to be determined because an earlier study from the same research group has shown that treatment of keratinocytes with TG affects neither DC glycosylation nor their gel mobility. 19 The study by Dhitavat et al. 19 contradict the notion of ER retention, 22 as post-ER processing of DC is expected to be affected if DC are retained in the ER. Here, we provide the first biochemical evidence that inhibition of SERCA2 impairs post-ER maturation of DC, demonstrating that SERCA2 activity is crucial for ER-to-Golgi transport of DC precursors.
| RESULTS

| Inhibition of SERCA2 impedes the transport of newly synthesized DC to the plasma membrane
Desmosomes are not assembled when epithelial cells are cultured in low calcium media (LCM), but they are assembled upon switching cells to high calcium media (HCM). 23, 24 Under LCM conditions, Dsc2/3 and Dsg3 in normal human epidermal keratinocytes (NHEK) are not detected on cell borders, but weak staining is revealed in the perinuclear regions ( Figure 1A -ATPase 2 (SERCA2) is inhibited. Normal human epidermal keratinocytes (NHEK) were cultured to subconfluence in low calcium media (LCM) (0.06 mM) and switched to high calcium media (HCM) (1.2 mM) medium overnight. Cells were subjected to immunofluorescence (IF) staining (A) or Western blotting (WB) analysis (B). C, Subconfluent NHEK cultured in LCM were switched to HCM in the presence of SERCA inhibitor thapsigargin (TG) (0.1 μM) or vehicle for 6 hours followed by IF staining. Scale bars = 10 μm. synthesized DC. At the time of HCM switch, we treated NHEK with control vehicle or TG, a highly specific and irreversible inhibitor of SERCA that has been widely used to study the consequences of ER Ca 2+ depletion. 27 The results show that TG treatment blocks Ca 2+ -induced transport of Dsc2/3 and Dsg3 to the cell borders ( Figure 1C ), which is consistent with the results by Dhitavat et al. 19 
| Inhibition of SERCA2 alters electrophoretic mobility of DC
We then analyzed DC by WB. Compared to control cells treated with vehicle, Dsc2/3 from TG-treated cells migrate much more slowly ( Figure 2A , upper panels), whereas Dsg3 migrates slightly faster ( Figure 2A , middle panels). These results were unexpected because a previous study has shown that DC mobility was not affected by TG treatment. 19 To confirm the results, we examined the effects of cyclopiazonic acid (CPA), a structurally distinct SERCA inhibitor that is less potent and reversible. 28 We observed identical mobility-shifted Dsc2/3 ( Figure 2B , upper panels) and Dsg3 ( Figure 2B , middle panels) from cells treated with CPA and TG. The result shows that stimulation of RyRs alone does not affect Dsc2/3 mobility but synergistically affects Dsc2/3 with an ineffective dose of TG ( Figure 2E ), supporting our hypothesis that alteration of Dsc2/3 mobility is caused by ER Ca 2+ reduction. We next examined the combining effects of SERCA2 silencing with an ineffective dose of TG (5 nM) and the result shows a synergistic effect on Dsc2/3 gel mobility ( Figure 2F ). Together, these data indicate that DC mobility change is a consequence of ER Ca 2+ reduction below a threshold level.
| Mobility-shifted DC are soluble in Triton X-100
Given the fact that newly synthesized Dsc precursor migrates at a slower rate on SDS-PAGE than its mature form, 31,32 whereas Dsg precursor migrates slightly faster than its mature form, 31 we speculated that the mobility-shifted DC are their immature precursors. As immature DC are soluble in non-ionic detergent, whereas mature DC are largely insoluble, 26, 33 we examined the solubility of DC in Triton X-100. Following overnight calcium switch in the presence of vehicle (V) or SERCA inhibitors (TG or CPA), cells were extracted into 1% Triton X-100 soluble and insoluble fractions and subjected to WB analysis ( Figure 3) . In control cells, Dsc2/3 and Dsg3 are predominantly present in the Triton X-100 insoluble fraction ( Figure 3A ,B, compare lanes 1 and 3). By sharp contrast, in SERCA2-inhibited keratinocytes (TG, CPA), the slower migrating Dsc2/ 3 is present only in the Triton X-100 soluble fraction, and no Dsc2/3 is present in the insoluble fraction ( Figure 3A ,B, upper panels, lanes 2 vs 4).
Similarly, the slightly faster migrating Dsg3 derived from SERCA2-inhibited (TG or CPA) keratinocytes is present only in the soluble fraction, and absent in the insoluble fraction ( Figure 3A ,B, middle panels, lanes 2 vs 4). These results show that the solubility of the mobility-shifted DC is consistent with the character features of their precursors.
| Loss of SERCA2 activity does not cause abnormal aggregates of desmosomal proteins
We also examined the solubility of desmosomal plaque proteins ( Figure 3C ). The results show that in control cells, more DP and PG are Figure 3A ,B, our data show that inhibition of SERCA2 reduces the insolubility of desmosomal proteins, which is against the notion that loss of SERCA2 activity causes abnormal aggregates of desmosomal proteins. 1 and 3) . Notably, in SERCA2-inhibited NHEK a small fraction of desmoglein 3 (Dsg3) with normal mobility is revealed in the insoluble pool (lane 4), whereas the faster migrating Dsg3 is in the soluble pool (lane 2). C, Solubility of desmosomal plaque proteins. TG treatment causes reduced levels of desmoplakin (DP) and plakoglobin (PG) in the insoluble fraction (compare lanes 3 and 4). Figure 5, panel d) . However, WB analysis shows no changes in its total expression level (data not shown).
| Dsc3 is retained in the ER in acantholytic areas of DD epidermis
To investigate whether ER retention of DC occurs in DD epidermis, we examined Dsc3 distributions on skin tissues obtained from DD patients (n = 3) and a normal subject. In normal control epidermis, In 
| MATERIALS AND METHODS
| Keratinocyte culture and treatment
Primary NHEK, obtained from Cascade Biologics, were cultured in EpiLife medium (0.06 mM calcium) supplemented with human keratinocyte growth supplement (HKGS) (Cascade Biologics). Cells at 3 to 5 passages were used for experiments. For SERCA inhibition, cells grown to confluence were treated with TG or CPA along with a high calcium (1.2 mM) switch for 6 hours or overnight (18 or 24 hours).
For controls, cells were treated with vehicle. TG and CPA were purchased from Sigma. 
| Protein extraction and WB
| SERCA2 knockdown
A pool of double-stranded siRNA oligonucleotide targeting human ATP2A2 gene and a non-targeting siRNA control were purchased from Dharmacon (SMARTpool, Thermo Scientific). NHEK were transfected with siRNA using TransMessenger Transfection Reagent (Qiagen) for 48 to 72 hours. The efficiency of SERCA2 knockdown was examined by WB using mouse monoclonal antibodies to SERCA2
(clone IID8, Millipore).
| Immunocytochemistry
NHEK plated on glass coverslips were grown to subconfluence and treated as described above. Cells were fixed, permeabilized, and stained with mouse monoclonal antibodies to Dsg3 (5G11, Invitrogen), Dsc2/3 (7G6, Invitrogen), or rabbit polyclonal antibodies to calnexin (Enzo Life Science).
| Immunohistochemistry
Paraffin 
